Facharzt FMH Allgemeine Innere Medizin Practice Questions - Facharzt FMH Für Allgemeine Innere Medizin Spécialiste FMH En Médecine Interne Générale Exam

Access More Questions

A 62-year-old male with a 40 pack-year smoking history is evaluated for chronic dyspnea and cough. Post-bronchodilator spirometry demonstrates an FEV1/FVC ratio of 0.58 and an FEV1 of 52% of predicted. Over the past 12 months, he experienced two severe COPD exacerbations requiring hospitalization. His peripheral blood eosinophil count is 350 cells/µL. According to GOLD 2024/2026 guidelines, which maintenance inhaler regimen is most appropriate?

Triple therapy: Long-Acting Muscarinic Antagonist (LAMA) + Long-Acting Beta2-Agonist (LABA) + Inhaled Corticosteroid (ICS) Short-acting beta2-agonist (SABA) monotherapy on an as-needed basis only Long-term oral prednisone 20 mg daily with theophylline Phosphodiesterase-4 inhibitor (roflumilast) monotherapy without bronchodilators

Correct Answer:

Triple therapy: Long-Acting Muscarinic Antagonist (LAMA) + Long-Acting Beta2-Agonist (LABA) + Inhaled Corticosteroid (ICS)

Access more questions from this quiz

Continue to Facharzt FMH Allgemeine Innere Medizin Practice Questions - Facharzt FMH für Allgemeine Innere Medizin Spécialiste FMH en médecine interne générale Exam for more practice questions and the full quiz experience.

Access More Questions